semaglutide effect on liver as a GLP-1 Agonist: A Breakthrough in Obesity Treatment Frontiers | Glucagon-like peptide-1 and

Its about what the body gives up in the process

2 Cooper Medical School of Rowan University, Camden, New Jersey, USA Correspondence: Garrett Chan, Email [email protected] Abstract: Tirzepatide is a GLP1/GIP receptor agonist that is used to treat type 2 diabetes and promote weight loss

Data extraction and quality assessment Two independent authors (NK and BA) identified articles and then extracted the following data regarding general characteristics of the study and population (study's first author, year of publication, study design and location, number of participants and their gender and age, intervention duration, and supplement dosage)

Researchers will measure heart problems (such as heart attack, or heart failure events), stroke, as well as changes in blood pressure, waist circumference, body weight, and A1C